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ABSTRACT 
A possible mechanism of pathogenicity of Bacteroides fragilis was 
determined while studying the interaction of rabbit peritoneal polymor-
phonuclear neutrophils (PMN neutrophils) with Bacteroides products 
(outer membrane and culture supernatant of~· fragilis VPI 9032, VPI 2553 
and ~· vulgatus VPI 4245; culture supernatant of B. thetaiotaomicron 
VPI 5482; and LPS of~· fragilis VPI 9032) . Neutrophils were elicited by 
injection of glycogen into the peritoneal cavity of rabbits and harvested 
four to seven hours later. 
When rabbit peritoneal neutrophils were exposed to Bacteroides 
products, the neutrophils released N-acetyl-S-glucosaminidase, a 
lysosomal enzyme. Bacteroides products also induced directional locomo-
tion (chemotaxis) of rabbit PMN neutrophils in Boyden chambers. The 
chemotactic response of rabbit neutrophils was dependent on the dosage 
of Bacteroides stimulant. 
The enzyme release response was greatly enhanced when Bacteroides 
products were pre-incubated at 37°c for 30 minutes with equal volumes of 
fresh guinea pig complement. However, when Bacteroides outer membrane or 
sterile culture supernatants were pre-incubated with fresh guinea pig 
complement, PMN neutrophil chemotaxis was retarded. 
Lactate dehydrogenase (a cytoplasmic marker) was not released upon 
exposure of rabbit PMN neutrophils to Bacteroides products. This 
indicated that the response to Bacteroides products reflect an active 
extracellular secretion of PMN neutrophil lysosomal contents rather than 
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a non-specific discharge of enzymes as a result of cell (PMN neutrophil) 
death. 
These findings suggest an altered inflammatory response of neutro-
phils during the interaction of Bacteroides with the host defense 
mechanism. 
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INTRODUCTION 
In recent years increasing emphasis has been placed on the role of 
obligately anaerobic microorganisms as the etiological agents of many 
human diseases. Bacteroides is the most common anaerobic organism 
isolated from bacteremia, intra-abdominal infections, and female genital 
tract infections (29, 39-44, 53, 62, 63, 71). Bacteroides fragilis 
attracts the most concern among the anaerobic non-sporing gram negative 
bacteria because it has been the most frequent clinical isolate (39-44, 
71). Bacteroides fragilis constitutes 60% of the strains of Bacteroides 
isolated from blood cultures, lung abscesses, soft tissues, infections 
of the intestinal and urogenital tracts (29, 71). Although~· vulgatus 
and B. thetaiotaomicron are the most frequent fecal isolates and out-
number~· fragilis in the large intestine of man (41); ~· fragilis is 
the predominant in intra-abdominal sepsis (29, 44, 62). ~· fragilis is 
unique because of its resistance to the S- lactam antibiotics (e.g. 
penicillin and cephalosporin) (44, 53). 
Common predisposing factors for Q_. fragilis infections are trauma 
(including surgery, perforating injuries, deliveries and abortions), 
vascular defects of the mucosal surfaces, systemic conditions such as 
diabetes melitus, leukemia, alcoholism, malignancy and immunosuppressive 
therapy which alter resistance to microbial invasion. Earlier views 
that anaerobes were present in infectious processes as microbial 
commensals with no role in the septic processes have been disproved by 
many studies (29, 39-44, 71). 
2 
Despite increased awareness of the importance of Bacteroides in 
infectious processes, relatively little information is available regard-
ing specific humoral and cellular host defense mechanisms against these 
gram negative non-sporing anaerobic microorganisms (10, 63) or the 
mechanism responsible for their pathogenicity (29, 61, 71). 
However, some studies have been done on the interactions between 
Bacteroides fragilis lipopolysaccharide and PMN neutrophils during 
inflammation (77, 78). An inflammatory response results from any injury 
to the tissue (e.g. following a mechanical injury or establishment and 
multiplication of microorganisms). The inflammatory response is a major 
mechanism used by the mammaliam immune system to destroy potentially 
toxic materials (59). Generally, inflammatory infiltrates are predomin-
antly PMN neutrophils (30). The accumulation of PMN neutrophils is of 
major importance to the host, since these neutrophils are intimately 
involved in the host defense against microbial invasion and in certain 
inflammatory disease states the neutrophils appear to be responsible 
for a large degree of the host-tissue destruction (as in acute necrotizing 
gingivitis) (73, 76, 79, 80, 89). 
The importance of complement in generating neutrophil chemotactic 
activity in serum reacted with immune complexes (antigen-antibody com-
plexes) was first demonstrated by Boyden in 1962 (14). More recently, 
Ward and others (85, 87, 90), have shown that serum complement is 
involved in opsonization, phagocytosis, vascular changes of acute 
inflammation and in amplifying the accumulation of phagocytes (neutrophils) 
at sites of chronic inflammation. 
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Phagocytosis and intracellular killing of microorganisms is a primary 
protective function of PMN neutrophils (10, 12, 14, 73). Bacteria produce 
soluble, diffusable materials (factors) detectable by PMN neutrophils some 
distance away (81). The PMN neutrophils unidirectionally migrate in the 
chemical gradient toward the source of the attractant. Polymorphonuclear 
neutrophils contain a wide variety of hydrolytic enzymes and substances 
which are directly responsible for the killing and digestion of bacteria 
and other engulfed particles (2, 4, 49, 50). 
Once at the inflammatory site, neutrophils also may release enzymes 
that intensify the influx of additional neutrophils as well as modulate 
the influx of mononuclear cells (89). The early local accumulation of 
these neutrophils at the sites of microbial invasion should aid in the 
rapid destruction of microorganisms and in healing of wounds. On the 
other hand, factors that delay or inhibit this early PMN neutrophil 
accumulation such as neutropenia, endotoxin (73), adrenalin administra-
tion or anti-inflammatory drugs, would allow for proliferation and 
probable dissemination of microorganisms in the host. 
The objective of this research was to investigate a potential mech-
anism of pathogenicity of Bacteroides fragilis by correlating in vitro 
chemotaxis of, and enzyme release by PMN neutrophils in response to 
Bacteroides fragilis, with i!!_ vivo virulence. The interactions of 
Bacteroides products ~terile culture filtrates (bacterial factors), outer 
membrane, and lipopolysaccharideLJ with PMN neutrophils which constitute 
the first line of the defense mechanism were determined and evidence 
was provided to support the hypothesis concerning the nature of the 
initial host response following contamination with B. fragilis. 
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LITERATURE REVIEW 
Polymorphonuclear (PMN) neutrophil responses to serum complement-
derived chemotactic factors, synthetic peptides and bacterial chemo-
tactic factors have been investigated for a number of years (32, 46, 70, 
84); however, a clear relationship between these factors and PMN 
neutrophils is yet to be defined. The majority of this work has been 
done with complement-derived chemotactic factors and synthetic peptides 
and little is known about chemotactic factors produced by bacteria. 
Infectious Microorganisms and Chemotaxis 
Although many pyogenic bacteria produce factors chemotactic for 
neutrophils, little or nothing has been done to purify or identify 
these chemotactic factors. Keller and Sorkin showed that culture fil-
trates of Staphylococcus aureus and Escherichia coli were chemotactic 
for PMN neutrophils (46, 47}; but they did not purify or identify the 
active components nor did they determine whether any difference existed 
between these two preparations. Ward, Lepow and Newman examined several 
bacteria isolated from human infections (91). They demonstrated that 
sterile culture filtrates from i· aureus, 0(-hemolytic streptococci, 
Streptococcus pneumoniae, f. coli, Proteus mirabilis, Proteus rettgeri 
and Hafnia species contained substances chemotactic for PMN neutrophils. 
Again these factors went essentially uncharacterized, except for a 
chemotactic factor produced by i· pneumoniae. The pneumococcal factor 
was described as heat-stable and non-dialyzable (91). 
Besides producing factors chemotactic for neutrophils, bacteria 
also produce inhibitors of chemotaxis. Bacterial toxins produced by 
s. aureus and Clostridium perfringens inhibit neutrophil chemotaxis 
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(93, 96). Weksler and Hill examined the effects of staphylococcal 
mucopeptide on the acute inflammatory response by evaluating its effects 
upon migration of PMN neutrophils (93). They showed that mucopeptide 
from a virulent strain of i· aureus, NCTC 9787, but not NCTC 7121 which 
was less virulent, inhibited the migration of PMN neutrophils toward a 
chemotactic stimulus in a Boyden Chamber (93). Virulent strains not 
only inhibit in vitro chemotaxis, but also enhance in vivo mouse virul-
- ---
ence in experimental infections. Hill previously demonstrated that 
mucopeptide from a mouse-virulent strain of i· aureus inhibited early 
edema and permitted lesion formation (93). 
Anaerobic Gram Negative Bacterial Products 
Kasper and Onderdonk have demonstrated that Bacteroides fragilis, 
an anaerobic, non-motile, gram negative bacillus has a cell wall similar 
to most gram negative bacteria (39-44, 62, 63). The outer membrane 
complex of~- fragilis contains a protein-lipid bi-layer with two poly-
saccharide components. One of the polysaccharide components, the lipo-
polysaccharide (endotoxin) was immunochemically and biologically identical 
to the lipopolysaccharide (LPS) extracted by the phenol-water technique 
(38, 40). The two polysaccharides were described as sharing hexose, 
hexosamine and methyl-pentoses. 
Hofstad and Kristoferson reported that LPS from~- fragilis NCTC 
9343, extracted by hot water-phenol lacked 2-keto-3-deoxyoctonate (KOO) 
and heptose, essential components of the inner core of most bacterial 
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LPS (37). The biologically active component of LPS is the KOO/lipid A 
region and the serological specificity of the glycolipid of the LPS is 
determined by the sugar residues attached to KOO (67). 
The LPS of gram negative bacteria contributes to virulence by 
inhibition of phagocytosis and by direct toxic effects (62). However, 
the LPS of~· fragilis differs from other gram negative bacteria, since 
it basically lacks toxicity (39-44, 62). 
Bacteroides LPS induces PMN neutrophil chemotaxis ~vivo and in 
vitro through the activation of complement (46, 77). Sveen et al showed 
that Bacteroides LPS was consistently less cytotaxigenic than the ref-
erence endotoxin (Salmonella LPS), Fusobacterium LPS and LPS from 
Veillonella {77, 78). 
Muschel suggested that the presence of a capsular polysaccharide 
may be responsible for the resistance of the organism to the bactericidal 
activity of the complement-antibody system (39). Subsequent observations 
by Kasper et~ that~· fragilis is encapsulated while other species of 
Bacteroides are not, focused attention on the capsule of~· fragilis as 
a major virulence factor (38, 39, 42). Kasper, Onderdonk and others 
demonstrated that the "capsular polysaccharide of B. fragilis was not an 
absolute requirement for abscess formation" in their rat experimental 
model even though "its presence correlated well with the percentage of 
recipients of abscesses" (62). 
The report of Lindberg et~ differed from that of Kasper demon-
strating that only 77% of~· fragilis and that 17% of~· ovatus, 
~· distasonis, ~· vulgatus, ~· uniformis and~· thetaiotaomicron isolated 
from clinical infections were encapsulated (53). The fact that an 
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antibody response to the capsular polysaccharide of~· fragilis has been 
demonstrated (42) further supports the pathogenic potential of an encap-
sulated Bacteroides. However, the outer membrane complex of Bacteroides 
is probably the best candidate for studying the virulence of Bacteroides 
{43) . The outer membrane contains the most important immunologic anti-
gens, and because of its location, the outer membrane is most readily 
accessible to the host defense mechanisms (43, 62). 
Classes of Neutrophil Chemotactic Factors 
Bacteria elaborate chemotactic factors in two ways: 
(i) they release small peptides of approximately 1,000 
molecular weight or larger (85) during bacterial 
replication (81, 85). These substances which directly 
stimulate directional migration of leukocytes are 
thought to attach to a site on the responding cell 
(46, 85, 96). These chemotactic factors have been 
named 11 cytotaxins" by Keller and Sorkin (46). 
(ii) they release enzymatic materials which cleave specific 
components of serum complement (third or fifth comple-
ment components) into chemotactically active fragments 
(C5fr and C3fr). These substances which have been 
named "cytotaxi gens" ( 46), 1 ack the abi 1 ity to directly 
stimulate locomotion in responding cells. Cytotaxigens 
unmask the presence of chemotactic mediators in serum 
resulting in the release of endogenous cytotaxins (12, 46). 
Harris, using time-lapse photography, provided strong evidence that 
bacteria elaborate factors chemotactic for neutrophils. He reported 
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that neutrophils in suspension moved about randomly; but, cells placed 
in the presence of bacteria moved unidirectionally toward a bacterium 
or its product(s) (91). 
Endogenous Complement Chemotactic Factors 
Complement is a series of nine proteins and is involved in several 
enzyme cascades in plasma. These cascades include, the coagulation 
system, the kinin system and the properdin system (92). During activa-
tion of complement and properdin, products are elaborated which: mediate 
changes in vascular permeability, attract PMN neutrophils and mononuclear 
cells, influence the release of lysosomal enzymes, enhance phagocytosis 
by promoting adherence of complement-coated complexes to formed elements 
in the blood (immune adherence) and damage cell membranes to induce 
osmotic lysis and cell death (2S, 8S, 92). 
Snyderman et ~have demonstrated that CSfr (CSa) is the major 
chemotactically active complement fragment derived through cleavage of 
complement by immune complexes (72, 73). They have also reported that 
interaction of endotoxin (LPS) with guinea pig complement (C') .1I!. vitro 
generated a low molecular weight chemotactic factor derived from C'S 
(72, 73). Trypsin (73, 91), cobra venom factor (72, 92), virus infected 
cells (2S, 9S), streptococcal protease (89), and gram negative bacterial 
protease (2S, 60, 86) also have neutrophil cytotaxigenic activity. Ward 
and Hill identified the lysosomal protease isolated from rabbit neutro-
Phils and showed that this protease could cleave human C'S into chemo-
tactic fragments of variable molecular weights (89). 
Ward, Cochrane and Muller-Eberhard reported that CS67, a heat-
stable factor, was chemotactic for neutrophils (81, 88). 
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C'3 fragment (C3a), a peptide, was also shown to be chemotactic 
(84) and anaphylatoxic (96). It is cleaved from C1 3 by the action of 
plasmin (84, 91), trypsin (99), tissue protease (90) and gram negative 
bacterial protease (84, 86, 96). 
Other proteins and some polysaccharides, for example peptone 
medium (46) and glycogen (9, 46, 73, 90) are cytotaxigenic; while pro-
ducts of cell damage and the supernatants from homogenized granulocytes 
are neutrophil cytotaxins (12, 90). 
Vasoactive substances such as bradykinin, kallidin, histamine and 
serotonin give no significant neutrophil chemotactic response (88). 
Role of Complement in Chemotaxis and Infections 
The role of serum complement in immune lysis (57), inflammation 
and in resistance to bacterial infections (5, 59) is well known. The 
complement system has been strongly implicated as the biologic mediator 
of acute inflammation (33-36) which mobilizes immune effector cells to 
an inflammatory lesion (73, 74, 90). This biologic activity is said to 
be mediated by activated complement components, C3a and C5a, which are 
believed to amplify the cellular components of the inflammatory response 
(30, 33, 73). 
Complement depletion affects the pathology of necrotic skin lesions. 
Easmon and Glynn induced skin lesions in animals with Staphylococcus 
aureus and showed that the ultimate dimensions of the lesions were pro-
portional to the number of PMN neutrophils in the early infiltrate (21). 
Tissue enzymes, capable of activating the complement system, released 
by neutrophils have been implicated in tissue destruction and associated 
with the infectious lesions (49). 
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Complement C5fr is not only chemotactic but, it can trigger 
neutrophils to undergo a burst of oxidative metabolism (13, 51). During 
this oxidative burst, oxygen is taken up from the extracellular medium 
and converted to superoxide anion (02) which leads to generation of 
hydrogen peroxide which coupled with halides (iodide, chloride) may act 
as substrate for the halogenation and destruction of bacteria by the 
myeloperoxidase system (13, 51). Formylated methionyl-tripeptides 
(e.g. N-formyl-methionyl-leucyl-phenyalanine) induce similar oxidative 
bursts in responding neutrophils. 
The importance of complement is highlighted by the findings that 
C'S-deficient mice showed deficient PMN neutrophil accumulation in 
response to local endotoxin; furthermore, these animals were more sus-
ceptible to microbial invasion than their CS-normal counterparts (73, 90). 
Although phagocytosis can proceed in the absence of complement 
activation, complement receptors on PMN neutrophils are important for 
clearance and phagocytosis of opsonized particles. Lay~~ reported 
complement factors (first 4 complement components) mediate binding of 
antigen-antibody complexes to neutrophil membranes during phagocytosis 
(48). 
Immunoglobulin and components of the alternative complement pathway 
participated in the opsonization of!!_. fragilis and!!_. thetaiotaomicron 
by promoting phagocytosis and intracellular killing (10). The Bjornsons 
showed that human serum depleted of immunoglobulin, C'3, factor B or D 
did not support human PMN neutrophil phagocytosis and intracellular killing 
of!!_. fragilis and B. thetaiotaomicron (10). 
Casciato et~ reported that under aerobic conditions, clinical 
isolates of B. fragilis and B. thetaiotaomicron were not susceptible 
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to human serum bactericidal activity (10). The Bjornsons however, 
demonstrated that under anaerobic conditions~- fragilis and~· 
thetaiotaomicron were phagocytosed and killed intracellularly by human 
PMN neutrophils in the presence of normal serum but not by either 
neutrophils or serum alone (10). 
Peterson et~ found that two major opsonic systems in serum were 
required for normal phagocytosis for staphylococci. One was a heat-
labile system dependent on C' and the other a heat-stable system mediated 
by immunoglobulin (64). 
Cellular Physiology of the Chemotactic Response 
Relationships between Chemotaxis, Enzyme release and Phagocytosis. 
Chemotaxis, phagocytosis and lysosomal enzyme release are all ex-
amples of movement. In chemotaxis, there is movement of the whole cell 
(7-9, 46); in phagocytosis, movement of the cell membrane and associated 
structures; and in lysosomal enzyme release the granules move from the 
interior of the cell to the plasma membrane (9, 92). Similar recognition 
mechanisms are thought to be responsible for both chemotaxis and phago-
cytosis (9, 96). Chemotaxis, phagocytosis and enzyme release require 
glycolysis for metabolic energy (8, 25, 96). Studies by Kreutzer et~ 
and Becker et~ demonstrated requirements for magnesium and calcium 
ions for optimal chemotaxis (8, 22, 70). 
In the absence of phagocytosis, enzyme release can occur by a process 
of "reverse endocytosis 11 (33, 34, 80) or exocytosis. This was demonstrated 
by experiments employing PMN neutrophils exposed to non-phagocytosable 
stimuli such as: large aggregates of dead or living plaque bacteria (80), 
irrrnune complexes attached to solid surfaces, surfaces too large to be 
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phagocytosed (33, 35), or sepharose beads coated with C'3b and immuno-
globulin (80). Electron microscooic studies revealed that exocytosis 
was apparently similar to the process following phagocytosis during 
which granular contents are discharged into the phagocytic vacuoles 
(35, 85). The only difference is that in exocytosis granules are dis-
charged directly to the outside of the cell, since the whole surface 
could not be engulfed by the PMN neutrophil. 
The respiratory burst and enhancement of hexose monophosphate 
shunt observed during phagocytosis is observed in cells stimulated by 
chemotactic factors (7, 35, 85, 95). Ward and others showed that 
interaction of neutrophils with chemotactic factors resulted in a 
respiratory burst, activation of hexose monophosphate shunt and produc-
tion of lactate (35, 85). These results were interpreted to mean that 
similar or parallel metabolic pathways are required for chemotaxis and 
phagocytosis. Becker et al demonstrated that the ability of a peptide 
(C5a or low molecular weight peptide isolated from£. coli culture 
filtrate) to induce PMN neutrophil migration correlated directly with 
its ability to induce lysosomal enzyme release from cytochalasin 
S-treated cells (70). 
Ward and Becker reported that the same enzyme, esterase 1, is 
activated both during chemotaxis and phagocytosis. Furthermore, in the 
absence of this enzyme, neither of these functions (chemotaxis and 
phagocytosis) can take place (7, 87). Bacterial factors, for unknown 
reasons, appear to activate a smaller proportion of the proesterase 1 
(inert form of esterase 1) of neutrophils than do complement derived 
chemotactic factors (7). 
13 
Ward and Becker found that after responding to a complement derived 
chemotactic stimulus (e.g. C567, C5fr, C3fr), PMN neutrophils became 
"deactivated 11 and were not able to respond chemotactically a second time, 
either to the same stimulus or any other chemotactic stimulus including 
bacterial factors (7, 86). In contrast, they reported that response of 
rabbit PMN neutrophils to bacterial factors or incubation of the PMN 
neutrophils with the bacterial factors did not induce deactivation to 
the bacterial factor nor to any of the complement derjved factors (7). 
Keller and Sorkin showed that although the phagocytosing neutrophil be-
comes unresponsive, it releases factors which attract other cells to the 
site of action (96). 
Microfilaments and Microtubules in the Chemotactic Response. 
The current hypothesis to explain the chemotactic response is that 
the microtubule system provides the net vector (polarized pseudopod 
formation) while the microfilament system, which requires local increases 
in cytoplasmic membrane calcium, provides the mechanical work for the 
motion of the neutrophil (26). 
The exact role of microtubules is unclear; however, evidence points 
to the view that they direct lysosomal granules toward stimulated exter-
nal membrane with which they interact (92). 
Microtubules may act as a cytoskeleton, maintaining the shape of the 
cell and in so doing aid movement of some distant granules to the vacuoles 
(92). The microfilaments (actinomysinoid material), which are contractile 
elements of the cell, are involved in secretion (92). Microfilaments 
also may move granules around in the cytoplasm and normally prevent access 
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of granules to the cell membrane; but by contracting, they allow freer 
access of granules to the cell membrane. 
Cytochalasin B, a fungal metabolite, paralyzes the microfilament 
system and reversibly inhibits the chemotactic migration of human and 
rabbit PMN neutrophils (36, 96, 100, 101). There is speculative evi-
dence that cytochalasin B, by disrupting microfilaments, allows greater 
movement of granules within the cytoplasm and thus enhances exocytosis 
of granules from PMN neutrophils (92). 
One role of microtubules, another contractile system in PMN neu-
trophils, has been suggested by the findings that colchicine and vin-
blastin (drugs which cause disruption of microtubules in human and 
rabbit neutrophils), inhibit neutrophil motility and lysosomal enzyme 
release at similar dose level (25, 92, 96). Therefore, it appears 
that secretion of lysosomal enzymes and chemotaxis depend upon the 
integrity of the cells' contractile elements 
Chemotaxis and Inflammation - Role in Host Defense 
Chemotaxis and Chemokinesis. 
In leukocyte chemotaxis, cells move unidirectionally toward the 
point of the highest concentration of the attractant, where they accumu-
late and movement against this gradient is inhibited. This is called 
"positive chemotaxis" (25, 46, 84, 96). Leukocytes may also migrate 
away from the source of a chemical gradient. This repulsion is called 
"negative chemotaxis" (96). 
Chemokinesis (random walk) has been defined as "a reaction by 
Which the speed or frequency of locomotion and/or the frequency and 
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magnitude of turns of the cells is determined by the substances in the 
environment" (25, 95). Substances that only increase the rate of 
locomotion without influencing directional migration of cells, may not 
necessarily cause the cells to accumulate; because once the cells reach 
the source of such substances there is no force to prevent them from 
moving away (96). Keller and Sorkin suggested that random motility and 
chemotaxis involve different cellular processes (46). They further in-
dicated that rabbit neutrophil chemotactic activity could be diminished 
without affecting random motion. 
Role of PMN Neutrophils in Host Defense 
Neutrophils, the classical cells of the inflammatory response, are 
considered part of the host's first line of defense (81). The role of 
PMN neutrophils in host defense reactions is related to their ability 
to engulf and destroy a wide variety of microorganisms (2, 19). 
Cohn and Hirsch reported the presence of destructive products in 
PMN neutrophil lysosomes and that these products are released during 
phagocytosis (19). The initial bactericidal event which occurs in the 
cytoplasm of the neutrophil may be mediated by a number of antimicrobial 
agents ~.g. phagocytin (a lysosomal cationic protein), lysozyme (94), 
and lactic acid present in the neutrophil in high concentrations and 
with potent activitie~ (19, 49, 76). In addition, neutrophils contain 
a variety of hydrolytic enzymes which may play a synergistic role in 
the digestion of engulfed particles; even though these enzymes are not 
directly responsible for bacterial inactivation (19). 
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Ronston suggested that the phagocytic N-acetyl-S-glucosaminidase, 
a hydrolytic enzyme of rabbit and human neutrophil lysosomes, may act 
synergistically with several intracellular enzymes to degrade Group A 
streptococcal cell wall within the PMN neutrophil (3). 
Electron microscopic studies by Taichman et ~indicated that 
degranulation and discharge of PMN neutrophil lysosomal enzymes were 
associated with phagocytosis of gram negative and gram positive bacteria, 
and with exocytosis of lysosomes from cells contacting large masses of 
aggregated plaque bacteria (80). 
Lysosomal Granules of Neutrophils. 
Two major granule types have been reported for PMN neutrophils: 
(i) a peroxidase positive granule (called 11 azurophil 11 or 
primary granule) 
(ii) a peroxidase negative granule (called 11 specific 11 or 
secondary granule) (33, 36, 76, 94, 95, 99). 
In rabbit neutrophils, the azurophilic granules contain acid hydrolases, 
whereas the specific granules contain alkaline phosphatase, lysozyme 
and lactoferin but are free of acid phosphatase (4, 33, 76). 
Myeloperoxidase has been used as a marker for azurophilic lysosomal 
granules and lysozyme is commonly used as a marker for specific granules 
even though lysozyme is not solely restricted to the specific granules 
(94). 
Neutrophils, during chemotaxis or stimulated by either phagocytosis 
or adherence to non-phagocytosable surfaces, release 8-glucuronidase, 
8-galactosidase, acid phosphatase and myeloperoxidase (which are known 
to reside mainly in the primary 11 lysosomal 11 or azurophilic granule) (33). 
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The presence of N-acetyl- 8-glucosaminidase activity in mammalian 
tissues has been reported by several investigators (3, 61, 65, 98) . 
Ayoub and McCarthy demonstrated the occurence of N-acetyl-8-glucosamin-
idase activity in mammalian neutrophils (3). They showed that N-acetyl-
S-glucosaminidase from phagocytic cells differed greatly from that ob-
tained from soil bacilli. Sellinger, Hay and others studied the intra-
cellular distribution of N-acetyl-8-glucosaminidase, an acid hydrolase, 
in various tissues (3). They showed this enzyme to be lysosome-asso-
ciated. 
llTITiunologic Release from Polymorphonuclear Neutrophils. 
Although several reports suggest that extracellular release of 
granular enzymes is a useful function of the inflammatory cell defending 
the body; it has also been suggested that in protecting the host from a 
generalized infection, the neutrophil may cause tissue damage at the 
site of phagocytosis (80, 81, 87). 
In immune vasculitis, tissue injury results from the inflammatory 
response itself rather than from the stimulus that evoked the response 
(87, 99). Neutrophils contain injurious constituents within their 
granules (e.g. Lysozyme). Neutrophil accumulation at the site of immune 
complex deposition is also accompanied by the phagocytosis of the com-
plexes (33, 35). During this process, some of the neutrophil granular 
contents may escape to the outside of the cell and cause tissue damage. 
Henson demonstrated that during exocytosis, granules are extruded directly 
to the outside environment of the cell (35) . Tissue damage occurs in 
such cases. Some examples of this are acute necrotizing, ulcerative 
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gingivitis and juvenile periodontal infections, where evidence showing 
that while phagocytosing large aggregates of plaque bacteria (by 
exocytosis), PMN neutrophils cause tissue destruction (18, 32, 80, 81). 
The release of bactericidal and bacteriostatic agents from neutro-
phils affects not only neutralization and killing of microorganisms, 
but also amplifies and localizes the inflammatory response (27, 99). 
Goetz and Austen have described a "neutrophil-immobilizing factor" 
released from PMN neutrophils following exposure to bacterial endotoxin 
(27). This immobilizing factor inhibited the response of human neutro-
phils to diverse chemotactic stimuli without affecting cell viability. 
Drugs Which Affect Chemotaxis 
Henson and others have reported that cytochalasin B prevents 
phagocytic uptake of particles by PMf~ neutrophils, by disruption of 
microfilaments (35, 101). They further stated that the inhibitory 
effect of cytochalasin B on glucose oxidation was due to the fact that 
cytochalasin B acts upon the cell membrane and thus inhibits transport 
of glucose into the cell (35, 92, 101). 
Showell, Kruetzer, Ward and others have demonstrated that inter-
action of chemotactic factors with cytochalasin B-treated cells (PMN 
neutrophils) enhances release of lysosomal enzymes (7, 36, 70, 89). 
Cytochalasin B reportedly acts by enhancing exocytosis (92). 
Zurier et ~reported that prior treatment of PMN neutrophils with 
cyclic nucleotides, prostaglandin E1 or with compounds that interfere 
with microtubule function (e.g. Vinblastin and Colchicine), blocked 
enzyme release (101). Henson et~ showed that lysosomal enzyme release 
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was inhibited by diisopropyl fluorophosphate and agents that increase 
intracellular concentration of cAMP (35). 
Ward confirmed the inhibitory effects of steroids, hydrocortisone 
and methyl prednisolone (anti-inflammatory drugs), on chemotaxis of gly-
cogen-induced rabbit peritoneal neutrophils (83). He showed that 
chloroquine, hydrocortisone and corticosteroids have a direct effect on 
PMN neutrophils rendering them incapable of responding to a chemotactic 
stimulus (25, 83). 
Aspirin, a non-steroidal anti-inflammatory drug (85, 92) apparently 
has no suppressive effect on chemotaxis. However, aspirin appears to 
suppress inflammation by blocking prostaglandin synthesis (85, 92). 
Disorders of Neutrophil Chemotaxis 
The discovery of syndromes involving defective neutrophil chemo-
taxis leading to increased susceptibility to bacterial infections adds 
strength to the arguments in favor of the essential role of chemotaxis 
in infections. One example of such syndromes is chronic granulomatous 
disease of childhood. It is characterized by recurrent, severe bacterial 
infections, dermatitis and chronic suppurative and granulomatous lymph-
adenitis (51, 57, 85, 96). 
In Chediak-Higashi syndrome, a familial leukotactic defect, children 
show defective neutrophil migration (18, 25, 60, 85). This syndrome is 
characterized by defective bactericidal activity in the presence of 
normal ability to ingest bacteria, partial occulomatous albinism, and 
a history of recurrent severe pyogenic infections. The presence of ab-
normal giant cytoplasmic lysosomal granules is inherent of the defective 
neutrophils. 
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In 1971, Miller et~ reported two children with depressed neutro-
phil mobility and recurrent infection. This syndrome was termed the 
"Lazy-Leukocyte-Syndrome'' (57). This syndrome is characterized by 
gingivitis, stomatitis and recurrent upper respiratory tract infections. 
The patients' neutrophils demonstrate normal capacity for phagocytosis 
and bacterial killing with abnormal membrane receptors for chemotactic 
factors. 
In diabetes melitus, neutrophils show a partially-defective chemo-
tactic response. This defect was corrected .i.!!. vitro by addition of 
insulin and potassium to the neutrophil suspension (60, 86) . 
Apart from the development of a new technique for measurement of 
leukocyte chemotaxis by Boyden (14); interest in chemotaxis has soared, 
because of the recognition of chemotactic defects in certain patients 
with chronic bacterial infections. 
Mowat et~ were the first to report evidence that severe infections 
may depress leukocyte function (60). They showed that neutrophils of 
patients with overwhelming bacterial infections, including tuberculosis 
infections, were less chemotactically responsive than neutrophils from 
healthy individuals. 
In 1969, Ward et al reported that a child who was subject to fre-
- -
quent gram negative bacterial infections had an inhibitor of human 
neutrophil chemotaxis in his serum. This inhibitor appeared to act 
directly on neutrophils, but did not affect the chemotactic stimulus 
(27). 
Ingham et~ reported that serum reacted with~· fragilis or~­
~laninogenicus was able to inhibit phagocytosis and killing of 
Proteus mirabilis by PMN neutrophils in vitro (38) . 
Defective neutrophil chemotaxis has been frequently associated 
with juvenile periodontitis (18, 80). 
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In 1974, Boxer et ~described a male infant with repeated bacterial 
infections and a poor..:!.!!. vivo inflammatory response in affected tissues 
{13). Their..:!.!!. vitro studies demonstrated defects in PMN chemotaxis and 
phagocytosis but enhanced degranulation (13). 
The only report concerning the effect of bacteria and their products 
on the migration of leukocytes was made by Martin and Chaudhuri (15). 
They stated that purified gram negative bacterial product (Typhoid soma-
tic carbohydrate) and whole Salmonella typhi (6xl0 6 org/ml) but not 
staphylococcus or pneumococcus inhibited the migration of human PMN 
neutrophils suspended in plasma (15). 
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MATERIALS AND METHODS 
Bacterial Strains 
Bacteria used in this study were obtained from Virginia Polytechnic 
Institute and State University (VPI), Blacksburg, Virginia. The three 
species of Bacteroides used were Bacteroides fragilis [YPI 9032, VPI 5383 
(ATCC 23745), VPI 2553 (ATCC 25285TI clinical isolates, Bacteroides 
vulgatus [YPI 4245 (ATCC 8482] a fecal isolate, and Bacteroides 
thetaiotaomicron ('YPI 5482 (ATCC 29184~ a fecal isolate. 
Stock cultures were maintained after growth for 24 hours at 37oc, 
at room temperature under oxygen-free co2 in pre-reduced chopped-meat 
broth {Appendix B). 
Preparation of Bacterial Chemotactic Factor 
The defined medium used in preparing the bacterial factor was a 
modification of the medium of Varel and Bryant (75). It contained per 
liter of distilled water: glucose, 5g; (NH4)2S04, lg; KH 2P04, 0.9g; 
NaCl, 0.9g; CaC1 2.2H20, 26.5mg; MgC1 2.6H20, 20mg; MnC1 2.4H20, 20mg; 
FeS04.7H20, 4mg; CoC1 2.6H2o, lmg; resazurin, lmg; and Vitamin B12• lOµg. 
The medium was adjusted to pH 6.5 with NaOH and sterilized at 1210C for 
15 minutes . To this medium, 20ml of sterile 25% (wt/vol) cysteine-HCl 
and 50ml of sterile 8% (wt/vol) Na 2co3 (each prepared in o2-free water 
and kept under an atmosphere of C02) were added asceptically under oxygen 
free co2. Under oxygen-free co2, ?ml aliquots of the medium were dis-
pensed into tubes and autoclaved in a press at 121°c for 15 minutes. 
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One half ml of stock culture of organisms was transferred by pipette 
into a ?ml tube of Varel and Bryant's modified defined medium under 
o2-free co2 and this culture was incubated at 37°c for 24 hours. The 
culture was centrifuged at 5000 x g for 30 minutes. The supernatant 
was carefully removed with a sterile pipette and then filter sterilized 
by passing the culture supernatant through membrane filters, 0.45µm 
pore diameter (Millipore Corporation, Bedford, Massachusetts). The con-
centrated cell suspension left in the tube of medium was checked for 
contamination. The sterile culture filtrates were stored at -20°c until 
used. 
Extraction of Bacteroides Lipopolysaccharide (LPS) 
Lipopolysaccharide was extracted from Bacteroides fragilis VPI 9032 
by the hot water-phenol extraction method of Westphal (37). 
1) Two tubes containing 25ml of Trypticase Yeast Extract Glucose 
(TYG) medium containing per liter of distilled water: Trypticase, lOg; 
Yeast extract, lOg; resazurin (25mg per lOOml of distilled water), 4ml; 
salts solution, 40ml; glucose, lOg; hematin (50mg hemin in lml of lN 
NaOH, add 99 ml of distilled water), lOml; adjusted to pH 7.0, were 
each inoculated with 0.5ml of stock chopped-meat culture of Bacteroides 
under o2-free co2 and grown overnight at 37°c. 
2) Fifty milliliters of an overnight TYG culture was added per 
liter of TYG which was then incubated for 24 - 48 hours. 
3) The bacterial cells were harvested by centrifugation at 12,000 x g 
for 10 minutes, washed 2x with 0.9% normal saline and frozen (-20°c). 
4) Cells (25g, wet weight) harvested from 10 liters were dried in 
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the following manner: 
a. 150ml of 95% ethanol (4°C) were added to the cells with 
stirring and the mixture was centrifuged at 12,000 x g 
for 10 minutes at 4°C. 
b. 150ml of acetone (4°C) was added to pellet. The pellet 
was resuspended then centrifuged at 12,000 x g for 10 
minutes at 4°c. 
c. The resulting pellet was resuspended in 150ml of diethyl 
ether (4°C) and centrifuged at 10,000 x g for 10 minutes 
at 4°c. 
5) The dried cells (approximately 5g) were pulverized and dried 
in a vacuum dessicator to a constant weight. 
6) 5g of dried bacteria were suspended in 70ml of distilled water 
in a 68°C water bath. 
7) 70ml of 90% (wt/vol) phenol (preheated to 68°C) were added with 
vigorous stirring. This was incubated for 30 minutes at 68°C with inter-
mittent agitation, then cooled to about 10°c in an ice bath. 
8) The mixture was centrifuged at 8,000 x g for 45 minutes, and the 
upper layer (which contains lipopolysaccharide, nuclei acids and poly-
saccharides) was aspirated off. 
9) To the phenol layer and insoluble residue, 70ml of water (68°C) 
were added, stirred and heated to 680C for 30 minutes. 
10) The mixture was cooled to 10°c in an ice bath and Step 8 was 
repeated. 
11) The combined aqueous layers were dialyzed against distilled 
water for three days with numerous changes of water to remove the phenol. 
12) The volume was reduced to about 14ml by reduced pressure 
evaporation at 40°C. 
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13) This was centrifuged for 15 minutes at 3,000 x g at 4°C and the 
pellet was discarded. 
14) The supernatant was lyophilized and this was designated crude 
lipopolysaccharide (LPS). 
15) The crude lipopolysaccharide was resuspended in distilled water 
(3g per lOOml) and centrifuged 105,000 x g for four hours. The pellet 
was resuspended in distilled water and centrifuged (105,000 x g for 
four hours) twice more. 
16) The pellet was resuspended in distilled water and centrifuged 
at 3,000 x g for 10 minutes and the pellet was discarded. 
17) The supernatant was lyophilized. 
Preparation of Crude Bacteroides outer membrane (40, 43). 
Under oxygen-free co2, two tubes containing 25ml Trypticase Yeast 
Glucose (TYG) medium, were innoculated with 0.5ml of stock chopped-meat 
culture of Bacteroides and grown overnight at 37°c. Fifty milliliters 
of an overnight TYG culture of Bacteroides was added per liter of TYG. 
This was allowed to grow for 24 - 48 hours at 37oc. All cultures were 
checked for contamination. Organisms were pelleted by centrifugation at 
12,100 x g for 20 minutes and then washed 2x in 0.05M phosphate buffer. 
Pelleted organisms were suspended in a buffer containing: 0.05M sodium 
Phosphate, 0.15M NaCl and O.OlM EDTA, and adjusted to pH 7.4 at 24°C 
(the final volume was about 1/50 of original culture). The cell suspen-
sion was incubated at 6ooc for 30 minutes and then passed through a 25-
gauge hypodermic needle, after which the suspension was mixed for 10 
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seconds in a Waring Blender. Organisms were pelleted from this suspen-
sion by centrifugation at 12,000 x g for 20 minutes at 4°C. The super-
natant was centrifuged at 80,000 x g for two hours at 4°C. The pellet 
(crude outer membrane) was lyophilized (freeze dried). 
Rabbit Peritoneal Exudate Cells 
The procedure used for harvesting rabbit peritoneal polymorpho-
nuclear neutrophils (PMN) is similar to that employed by other investi-
gators (22, 70). Adult New Zealand White Rabbits (Glouchester Rabbitry, 
Chepachet, Rhode Island) were injected intraperitoneally with lOOml of 
sterile 0.1% (wt/vol) glycogen in isotonic saline. Four to seven hours 
later, lOOml of sterile heparinized-saline (5 units heparin/ml) were 
introduced into the peritoneal cavity. The peritoneal exudate was with-
drawn via 16 gauge canula into plastic containers by gravity drainage. 
These rabbits had been repeatedly primed with 0.1% glycogen in saline to 
produce large numbers of exudate cells prior to their use in these ex-
periments. Rabbits were not injected with glycogen-saline more than 
once in every three weeks. Any contaminating erythrocytes in peritoneal 
exudates were lysed with NH4c1, pH 7.3, and exudates contaminated with 
large amounts of erythrocytes were discarded. The rabbit peritoneal 
exudates were centrifuged in plastic tubes at 1,000 x g for five minutes 
at 4°C. Pelleted peritoneal PMN neutrophils were washed twice with at 
least 30ml of sterile normal saline. A concentrated cell suspension of 
the peritoneal PMN neutrophils was made in saline. Wright stained 
smears and wet mount differential counts revealed that this suspension 
contained 98% PMN neutrophils. Appropriate dilutions of the concentrated 
cell suspension were made in Hank's balanced salts solution (HBSS) 
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containing 0.05% (wt/vol) Bovine serum albumin. For chemotaxis assays 
2.5 x 10 6 cells/ml were employed whereas 1 x 10 7 cells/ml were routinely 
used for enzyme release assays. 
Chemotaxis Chambers 
Modified Boyden Chambers with steel housing were used for Chemotaxis 
experiments. The chambers were assembled with a 25mm coverslip; a soft 
silicone rubber gasket (25mm outside diameter and 19mm inside diameter); 
pre-tested membrane filter, 25mm diameter, 0.8µm porosity, and 150µm 
thick; another gasket; a 25mm coverslip again, and then closed with a 
screw top. The chamber was thus separated into an upper and a lower com-
partment with a membrane filter separating the two compartments. The 
lower chamber was loaded by injecting the material (about 0.8ml) tested 
for chemotactic activity or HBSS with a tuberculin syringe (26 gauge 
needle) through one of the ports at the side of the Boyden chamber. While 
filling the compartment, a needle was placed in the opposite port to allow 
air to escape. The material in the lower compartment was allowed to 
diffuse through filter to the upper compartment of the filter to produce 
a concentration gradient. A lml aliquot of rabbit peritoneal PMN neutro-
phils was placed in the upper compartment of each Boyden chamber. When 
bacterial products (culture filtrates, outer membrane and LPS) were 
tested for ability to induce random locomotion (chemokinesis)/or directed 
migratory response (chemotaxis), they were added to both the upper and 
lower compartments in varying concentrations, in keeping with the method 
described by Zigmond and Hirsch (100). All filters used in this study 
were from one batch, tested and proven membrane (Pathology Department, 
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University of Connecticut, Health Center, Farmington, Connecticut). 
This incubation period was chosen because upon testing the membrane 
filters, the greatest difference between the number of cells moving into 
the filter with no chemotactic stimulus in the lower compartment (back-
ground) and the maximum number of cells moving into the filter in re-
sponse to a chemotactic attraction from the lower compartment was found 
after one hour incubation. Duplicate chambers were incubated at 37°C 
for 60 minutes. 
Polymorphonuclear Neutrophil Chemotaxis Measurement 
Modified Boyden Chambers were disassembled after the appropriate 
incubation period. A procedure similar to that of Boyden (14) was used 
to process the membrane filters. A brass cassette (Schleischer and 
Shuell) which permits simultaneous staining of 25 filters was used to 
facilitate this process. Micropore filters removed from dismantled 
chambers were quickly immersed in 100% isopropyl alcohol and fixed for 
3 minutes. The cells on the filters were stained as follows: 
a. Erhlich's hematoxylin 6 - 10 minutes. 
b. Rinsed in distilled water 30 seconds. 
c. Blueing agent (20g MgS04, 2g NaHco3;1 liter of distilled 
water) 6 - 10 minutes. 
d. Rinsed in distilled water 30 seconds. 
e. Dehydrated in 70% isopropyl alcohol, two minutes. 
f. 95% isopropyl alcohol, two minutes. 
g. 100% isopropyl alcohol, two minutes. 
h. 100% isopropyl alcohol again, two minutes. 
i. Filters were cleared in xylene. 
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The filters were mounted on microscope slides with permount (Fisher 
Scientific Company, Pittsburg, Pennsylvania). The high power objective 
(40X) and lOx ocular of a microscope were used to count the cells; 
while the micrometer of the fine adjustment was used to measure the 
distance from the top of the membrane filter to the farthest plane of 
focus still containing two cells. This distance was measured for at 
least three random (ocular grid) fields. Duplicate chambers were 
assayed and the data represent the mean measurements of the two membrane 
filters examined. Increases in distance travelled into the membrane 
filter of lOµm above negative control by PMN neutrophils migrating 
toward an attractant are statistically significant (25). 
The Chemotactic Index (CI, the average distance that cells migrate 
in one hour at 37°C) was calculated in the following manner: 
Cells in focus were counted at each lOµm from original 
monolayer to the distant plane of the membrane filter. 
The number of cells counted per level was multiplied by 
the distance (in µm) of that level from the starting mono-
layer. The sum of the products obtained was divided by 
the total number of migrated cells. 
Chemotactic Factor Derived From Human Complement 5th Component (C5fr) 
The purified C5ff was supplied by Donald L. Kreutzer of the 
University of Connecticut Health Center, Farmington, Connecticut. The 
chemotactically active C5fr were stored at -20°c in 0.5ml aliquots. 
The solution was thawed before use and 1.5ml of 0.5M dibasic sodium 
Phosphate pH 7.2 - 7.4 was added. Chemotactic activity of the C5fr.· 
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was normalized by determining the quantity of C5fr that produced 50% 
of the maximal chemotactic response in Boyden Chambers (22). Three 
times this quantity of C5fr was used to assure consistent maximum 
chemotaxis and enzyme release from one cell preparation of polymorpho-
nuclear neutrophils to another. 
Induced Lysosomal Enzyme Release 
The ability of Bacteroides products, C5fr, Varel and Bryant's 
defined medium, and HBSS buffer to trigger the release of N-acetyl-S-
D-glucosaminidase from rabbit peritoneal PMN neutrophils was assayed 
by an adaptation of the Method of Wollen~~ (3). p-nitrophenyl 
N-acetyl-S-D-glucosaminide was the substrate for determining amount of 
enzyme released. 
Washed rabbit peritoneal exudate cells were suspended at a final 
concentration of 1 x 10 7 cells/ml in Hanks balanced salts solution con-
taining 0.05% (wt/vol) Bovine serum albumin. One µg of a stock solution 
(4mg per ml, in dimethyl sulfoxide) of cytochalasin B (Sigma Chemical 
Company, Milwaukee, Wisconsin) was added per ml of cell suspension. 
Dimethyl sulfoxide has no effect on the enzyme release response (70). 
Cells, samples tested, and tubes used in these experiments were all 
equilibrated at 4°c, except where otherwise stated. One-half milliliter 
of cell-cytochalasin B suspension was quickly added to 50µ1 of test 
material ~nown chemotactic factor (C5fr), buffer (HBSS), or bacterial 
producf} in plastic tubes. The mixtures were incubated for five minutes 
in a 37°c gyrotory water bath shaker. Release is completed in one minute 
or less under these conditions (70). Tubes were centrifuged at 2,000 x g 
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for five minutes at 4°C. The cell supernatants were transferred to 
clean tubes for assay of N-acetyl-S-D-glucosaminidase activity. Aliquots 
of these supernatants were kept (at 4°C) for measurement for lactate 
dehydrogenase. Cell pellets were discarded. 
N-acetyl-S-D-glucosaminidase Assay 
Equal volumes (0.5ml) of freshly prepared p-nitrophenyl N-acetyl-
S-D-glucosaminide (1.4mg per ml in 0.05M sodium citrate . buffer, pH 4.5) 
and cell supernatant were mixed by vortex. Mixtures were incubated at 
37oc in a gyrotory shaking water bath for one hour. Following incuba-
tion 0.5ml of glycine buffer (0.4M, pH 10.5), was added to the mixture 
to stop the reaction. p-Nitrophenol (a yellowish colored compound) was 
liberated from the substrate in the presence of N-acetyl-S-D-glucosamin-
idase. Absorbance was read at 410nm in a Gilford spectrophotometer. 
Positive (C5fr) and negative (HBSS) controls were included with each 
assay. Additional control mixtures containing only bacterial products 
were employed to demonstrate that these bacterial products had no 
glucosaminidase activity. All tests were performed in triplicate. 
Lactate Dehydrogenase (LOH) Assay 
Bacteroides products were assayed for the ability to trigger lysis 
of the peritoneal exudate cells and release lactate dehydrogenase (a 
cytoplasmic enzyme) from rabbit peritoneal neutrophils according to the 
method in Biochemical Information (11). This is a standard assay which 
measures the oxidation of reduced nicotinamide adenine dinucleotide 
(NADH) during the reduction of pyruvate to lactate. 
NAO+ 
r~-0 
lH3 
NADH~ 1 
lactate dehydrogenase ) 
Pyruvate 
roo-
HO-r-H 
~H3 
L - lactate 
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The reaction mixture contained: 2.83ml of O.lM phosphate buffer, 
pH 7.0 (530mg KH 2Po4 + 1.39g K2HP04 · 3H20/100ml, cooled at 4°c in an 
ice bath); O.lml of 23mM sodium pyruvate solution (25mg sodium pyruvate/ 
lOml, cooled to 4°C in an ice bath); and 0.05ml of 12mM NADH solution 
(lOOmg NADH, Na2 - salt/lOml, cooled to 4°c in an ice bath). 
The enzyme reaction was initiated by addition of 0.02ml of cell-
free supernatant. Absorbance at 340nm (A340 ) was read after one, two, 
three, four and five minutes. Change in A340 per minute (6A340) was 
used to report the level of lactate dehydrogenase activity. All assays 
were performed in triplicate. 
Reagents 
Cytochalasin B, p-nitrophenyl-S-0-glucosaminide, and guinea pig com-
plement were obtained from Sigma Chemical Company, Saint Louis, Missouri. 
All other reagents used in this study were of analytical grade. 
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RESULTS 
Induction of PMN Locomotion 
The crude outer membrane (OM) of Bacteroides fragilis (VPI 5383) 
was assayed at various concentrations to determine possible chemotactic 
activity for PMN neutrophils. The response of rabbit peritoneal PMN 
neutrophils was positive for locomotion, and the level of response was 
dependent upon the amount of OM added (Figure 1). Cell-free culture 
filtrates (CF) of~· fragilis (VPI 9032) and~· thetaiotaomicron (VPI 
5482) showed a similar positive chemotactic response to increasing doses 
(50µ1 to 150µ1). 
Bacteroides were cultured in a defined medium formulated by Varel 
and Bryant (75). Table 1 gives the results for the positive and nega-
tive controls included in the chemotaxis experiments employing Boyden 
chambers. The buffer, Hank's balanced salt solution (HBSS), gave no 
locomotion of PMN neutrophils; nor did several concentrations of fresh 
sterile Varel and Bryant defined minimal medium. The positive control, 
activated C5 fragment of serum complement, always elicited positive 
chemotaxis; demonstrating that the rabbit PMN neutrophils used in the 
assay were indeed responsive to chemotactic stimuli. 
Chemotaxis versus Chemokinesis 
Figure 2 demonstrates the response of rabbit PMN neutrophils to 
B. vulgatus (VPI 4245) OM was indeed Chemotactic (locomotion directed 
toward a concentration gradient). When concentrations of 50 to 150µg 
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of OM were added to the lower compartment, movement toward the lower 
compartment increased. When 50µg of OM were added to the upper com-
partment movement of PMN neutrophils was only observed when the concen-
tration of OM in the lower compartment was above 50µg. When the OM 
concentration in the upper compartment was increased to lOOµg, downward 
movement of the PMN neutrophils was only observed when the OM concen-
tration in the lower compartment exceeded lOOµg. Finally when the upper 
compartment contained 150µg of OM, there was no movement of the PMN 
neutrophils toward the lower compartment . 
Interaction of Bacteroides Cellular Components or Products with Rabbit 
PMN Neutrophils. 
Lipopolysaccharide (LPS), CF and OM of!!_. fragilis showed some 
chemotaxis of rabbit PMN neutrophils (Table 2). The activity of the 
LPS of!!_. fragilis (VPI 9032) was increased significantly by pre-incu-
bation with guinea pig complement at 37°c for 30 minutes; while the CF 
and OM gave a very negative reaction with PMN neutrophils after pre-
incubation with guinea pig complement (Table 2). There appeared to be 
an inhibitor of chemotaxis produced when CF or OM was pre-incubated 
with guinea pig complement. 
When the purified C5 fragment of complement was reacted with CF or 
OM, the chemotactic response of PMN neutrophils was significantly re-
duced; however, not back down to the negative control level (Table 3). 
When the amount of OM (VPI 5383) was increased to 62 .5µg/ml, the chemo-
tactic activity of the C5 fragment was completely abolished. 
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J.!lduction of Exocytosis of N-acetyl- B-glucosaminidase from Cytochalsin 
B-treated Rabbit PMN Neutrophils by Bacteroides Cellular Components or 
Products. 
Culture filtrate of~· fragilis (VPI 2553 and VPI 5383) and!!_. 
vulgatus (VPI 4245) caused a slight exocytosis of N-acetyl- B-glucosamini-
dase (Table 4). The LPS of!!_. fragilis (VPI 9032) and OM (VPI 2553, 
VPI 5383 and VPI 9032) did not cause any significant exocytosis (Table 4). 
However, when the CF, LPS or OM were pre-incubated with guinea pig 
complement at 37°c for 30 minutes, they released as much or more N-acetyl-
8-glucosaminidase activity from the cytochalasin B-treated neutrophils 
as the CS fragment (Table 5). No significant difference was observed 
when the guinea pig complement was added to the reaction mixture and 
assayed without pre-incubation. When the guinea pig complement was heat-
inactivated (ss0 c for 30 minutes) prior to mixing Bacteroides cellular 
components or products, the exocytosis response was reduced by about 
one-half. When these cellular components or products of Bacteroides were 
incubated in the reaction mixture, in the absence of PMN neutrophils, no 
color developed; indicating that the bacteria had no N-acetyl- B-glucosa-
minidase activity. Furthermore, no detectable level of lactate dehydro-
genase could be measured in the positive exocytosis reaction mixtures; 
indicating that PMN neutrophil lysis was not required for the release 
of N-acetyl- B-glucosaminidase, because lactate dehydrogenase is only 
found free in the cytoplasm of PMN neutrophils. 
36 
Figure 1. Dose response of rabbit PMN neutrophils 
to Bacteroides fragilis (VP! 5383) outer membrane 
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Table 1. Chemotactic Response of Rabbit PMN 
Neutrophils to the Defined Medium of Varel and Bryant 
Chemotactic Activit Additions to 
(d (c) 
Lower Com artment PMN neutro hils/2HPF (mean ± sd) Chemotactic Index 
Dept = lOµm 
None (HBSS) 20.5±4.2 0 
Varel and Bryant 
Defined 
(a) Medi um: · 50µ 1 12±2.1 0 
100µ1 11±2 .1 0 
150µ1 15.5±0.35 0 
C5 fragment, 30µ1 
(Positive Control) 31±3.0 18.5 
±3.8 
30µm 
0 
0 
0 
0 
3.5 
±0.95 
40µm 
0 
0 
0 
0 
0.25(b) 
±0.25 
10.0 
10.0 
10.0 
10.0 
14.8 
a) Each concentration of Varel and Bryant defined medium was added to 
HBSS (0.8 ± 0.2ml) in lower compartment 
b) Value not included in calculating Chemotactic Index (average distance 
traveled per neutrophil), because leading front cells were less than 
2. 
c) The Chemotactic Index is the average distance (in µm) the PMN neutro-
phils have penetrated into the membrane filter in one hour at 37°c. 
d) The values represent the mean cell count (± sd) in two high power 
fields for duplicate chambers. 
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Figure 2. Locomotion of Rabbit PMN Neutrophils in 
Established Gradients of Bacteroides vulgatus VPI 4245 outer membrane 
A. 
Concentration 
of OM 4245 
Above Filter 
0 
50 
100 
150 
B. 
Concentration 
of OM 4245 
Above Filter 
0 
50 
100 
150 
Chemokinesis 
PMN Neutro~hils/4 H. P.F. (mean ± SEM)(a) 
(µg/ml) 
0 
3.0( ±1.7) 
2.8( ±1.7) 
Chemotactic 
(µg/ml) 
10.0 
10.0 
10.0 
Concentration of OM 4245 
Bel ow Filter 
50 100 150 
46.3( ±9.4) 47.5( ±5.2) 
40.3( ±8.5) 
8.0( ±4.5) 
Index(b) 
Concentration of OM 4245 
Below 
50 
10.0 
10.0 
Filter 
100 
10.92 
10.0 
150 
11.89 
10.50 
a) Values represent the mean (± SEM) number of neutrophils per 
high power (400x) field [four high power fields were counted for 
duplicate Boyden chamber]) . 
b) The values represent the average distance (µm) traveled per neutrophil 
from the top of the filter toward the bottom. 
Table 2. Rabbit PMN Ne utrophils Response to Bacteroides 
fragilis Cellular Components or Products in the Presence 
and Absence of Guinea Pig Complement 
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Addition to 
Lower Compartment 
Chemotactic Activity (a) 
PMN Neutrophils/4 Chemotactic 
H.P.F. (mean ± SEM) Index 
None (HBSS) 
Culture filtrate (CF) VPI 5383(c)(50µl)(b) 
Lipopolysaccharide (LPS) VPI 9032 
(62.5µg) 
Outer membrane (OM) VP! 2553 (62.5µg) 
Outer membrane (OM) VP! 5383 (62.5µg) 
Outer membrane (OM) VP! 9032 (62 .5µg) 
CF VP! 5383 +Guinea pig comp . (37°c)(b) 
LPS VP! 9032 + Guinea pig comp. (c) (37°c) 
OM 2553 + Guinea pig comp. (c) (37°c) 
OM 5383 + Guinea pig comp. (c) (37°c) 
OM 9032 + Guinea pig comp. (c) (37°c) 
C5fr (30µ1 , Positive Control ) 
58±3.9 
257±4.4 
66±4 .9 
62.5±7.0 
83±4.2 
88±19.3 
18. 5± 13 . 1 
75.8±14.4 
53.3±6.4 
24.3±1.4 
10.0±7 . l 
152±11.5 
10 .0 
12 .14 
11.17 
10.94 
11.20 
12.29 
10 . 0 
13.27 
10 .0 
10.0 
10.0 
13 . 56 
a) Chemotactic Index is the average distance {µm) traveled per neutrophil 
from the top of the filter toward the bottom. 
b) These were from another exper iment having control values of 17.3±3.1 
PMN neutrophils /4 H.P.F. ± SEM and 10 .0 Chemotactic Index for no 
additions and 394±39.6 PMN neutrophils/4 H.P.F. ± SEM and 17.06 
Chemotactic Index for 30µ1 of C5fr (in 0.8 to lml HBSS) . 
c) lml of culture filtrate or lml of HBSS containing 62.Sµg OM or LPS was 
added to lml of guinea pig complement and incubated at 37°C for 30 
minutes. 0.8 to 1.0 ml of one of these mixtures was added to the 
l O\~er compa rtment of the Boyden chambers . 
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Table 3. Rabbit PMN Neutrophils Chemotactic Response 
to C5 Fragment in the Presence and Absence of Bacteroides 
fragilis VPI 5383 Cellular Components or Products 
Addition to 
Lower Compartment 
None (HBSS) 
C5fr (30µ1) 
Culture filtrate (CF) VPI 5383 (50µ1) 
Outer membrane (OM) VPI 5383 (62.5µg) 
CF VPI 5383 + C5fr(a) 
OM VPI 5383 + C5fr(a) 
Chemotactic Activity 
PMN Neutrophils/4 Chemotactic 
H.P.F. ± SEM Index 
17.3±2.2 10.0 
394±28.0 17.06 
257±4.4 12.14 
237±13.8 12.83 
313±23. 4 14.29 
301±49.8 14.6 
a) One ml of CF or HBSS containing (62.5µg/ml) OM was added to lml of 
HBSS contain i ng 30µ 1 of C5fr. This was incubated at 37°c for 30 
minutes, then 0.8 - 1 ml of the mixture was added to the lower com-
partment of Boyden chambers. 
Table 4. N-acetyl-8-glucosaminidase Activity(a) Released 
From Cytochalasin B-treated Rabbit PMN Neutrophils in 
Response to Cellular Components or Products of Bacteroides 
Additions to Reaction Mixture(b) 
None 
C5fr (50µ1, positive control) 
Culture Filtrate VPI 2553 
Culture Filtrate VPI 4245 
Culture Filtrate VPI 5383 
Lipopolysaccharide VPI 9032 
Outer membrane VPI 2553 
Outer membrane VPI 5383 
Outer membrane VPI 9032 
(0.587±0) 
0.993±0 
0.093±0.004 
0.114±0.01 
0.080±0.005 
0.040±0.01 
0.043±0.12 
0.043±0.04 
0.046±0.06 
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a) The reaction mixture contained: 0.5ml of 4mM solution of p-nitro-
phenyl - N-acetyl- 8-glucosaminide in 0.5M sodium citrate (pH 4.5), 
and 0.5ml of test sample. The mixture was incubated at 37°C for 
one hour, then terminated by addition of 0.5ml of 0.4M glycine 
buffer (pH 10.5) and the absorbance at 410 nm was read in a spectro-
photometer. 
b) The reaction mixture contained: 0.5ml of cytochalasin B-treated 
rabbit PMN neutrophils (5 x 106 cells), and 0.05ml of sample (CF or 
HBSS containing 62.5µg/ml of OM or LPS). The mixture was incubated 
for five minutes at 37oc, centrifuged at 2000 x g for five minutes, 
and the supernatant was assayed for N-acetyl-8-glucosaminidase. 
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Table 5. N-acetyl-S-glucosaminidase Activity Released From Cytochalasin 
B-Treated Rabbit PMN Neutrophils in Response to Bacteroides Cellular 
Products or Components Pre-Incubated at 37°c with Guinea Pig Complement 
for 30 minutes(a) 
Addition to Reaction Mixture 
None 
C5fr (50µ1, Positive Control) 
Culture Filtrate VPI 2553 
Culture Filtrate VPI 4245 
Culture Filtrate VPI 5383 
Lipopolysaccharide VPI 9032 
Outer membrane VPI 2553 
Outer membrane VPI 2553 
Outer membrane VPI 9032 
Refer to Table 4 for assay procedure. 
0.587±0 
0.993±0 
1.044±0.045 
1.282±0. 24 
1.251±0.29 
1.096±0.07 
1.473±0.06 
1.276±0.04 
1.219±0. 04 
a) lml of CF or HBSS containing (62.5µg/ml) of OM or LPS was added to 
lml of guinea pig complement and incubated for 30 minutes at 37oc, 
prior to adding 50µ1 of this mixture to the cytochalasin B-treated 
PMN neutrophils. 
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DISCUSSION 
The observations reported here indicate that both outer membranes 
and culture filtrates of Bacteroides fragilis (VPI 5383, VPI 9032, VPI 
2553) and B. vulgatus (VPI 4245) induced PMN neutrophil chemotaxis. 
Furthermore, when guinea pig serum complement was incubated with outer 
membranes or culture filtrates of.!!_. fragilis (VPI 2553, VPI 5383, VPI 
9032) or.!!_. vulgatus (VPI 4245) or the lipopolysaccharide of.!!_. fragilis 
(VPI 9032), the release of N-acetyl-8-glucosaminidase from cytochalasin 
B-treated PMN neutrophils was induced. 
In contrast, PMN neutrophil chemotaxis was markedly diminished 
when Bacteroides crude outer membrane or culture filtrates were preincu-
bated (at 37°c for 30 minutes) with guinea pig serum complement. These 
findings suggest that an inhibitor of neutrophil chemotaxis may be gen-
erated upon interaction of Bacteroides outer membrane or sterile culture 
filtrates with guinea pig complement. The fact that this factor (or 
inhibitor of neutrophil chemotaxis) was able to increase enzyme release 
of PMN neutrophils; while at the same time inhibit chemotaxis, suggests 
that either different PMN neutrophil receptors were triggered or the 
neutrophil receptors responsible for chemotaxis inhibition and enzyme 
release are identical or situated in the same vicinity, such that once 
one receptor is triggered the other is also. 
Casciato et al indicated that different metabolic pathways may be 
involved in neutrophil movement, depending upon the mechanism that 
produced the chemotactic factor (17). Whereas chemotaxis in response 
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to factors produced by whole Staphylococcus aureus, Escherichia coli 
and!· fragilis suspended in plasma was depressed under anaerobic con-
ditions, chemotaxis induced by factors generated from immune complexes 
suspended in plasma was identical under aerobic and anaerobic conditions 
(17). Hence, they suggested that suspension of bacteria in plasma might 
have produced an inhibitor of neutrophil chemotaxis. Indeed, inhibitors 
of chemotaxis produced by soluble products, purified Typhoid somatic 
carbohydrate (15), bacterial toxins liberated from S. aureus (93) and 
Clostridium perfringens (97) have been demonstrated. 
The factor produced when Bacteroides cellular components or pro-
ducts (outer membrane and culture filtrates) were incubated with guinea 
pig complement may have induced a shock effect on the neutrophils, re-
sulting in inhibited locomotion or altered inflammatory response; 
mimicking the Leukopenia evidenced in the j__Q_ vivo response to bacterial 
endotoxin. This possible relationship was previously discussed by 
Martin and Chaudhuri (15). 
Previous studies dealing with interactions of synthetic peptides 
and neutrophils suggested that there may be a common receptor for chemo-
taxis, lysosomal enzyme secretion from neutrophils and phagocytosis (45, 
70). Our findings do not necessarily contradict the previous studies; 
however, the data indicates that the two neutrophil functions, inhibited 
locomotion and enzyme release, may be triggered by the same factor 
generated upon incubation of Bacteroides outer membrane or culture 
filtrates with guinea pig serum complement. 
This report demonstrates that Bacteroides LPS, outer membrane and 
culture filtrates possess low chemotactic activity and enzyme releasing 
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effect on neutrophils in comparison with the C5 fragment. This agrees 
in part with earlier findings by Sveen and others who showed Bacteroides 
LPS possesses chemotaxigenic activity for leukocytes (77, 78). Our find-
ings also support the report that the interaction of Bacteroides LPS 
with serum complement leads to increased neutrophil chemotaxis (77, 78); 
thus demonstrating Bacteroides LPS is cytotaxigenic. Our data showing 
that: (i) Bacteroides outer membrane and culture filtrates induce low 
level chemotaxis and enzyme release; and (ii) incubation of the same 
Bacteroides cellular components or products with guinea pig complement 
resulted in increased enzyme secretion and retarded neutrophil locomotion, 
add credence to the suggestion that different receptors are involved in 
PMN neutrophil locomotion and enzyme release (in response to Bacteroides 
cellular components or products). Another possibility might be that the 
neutrophil receptor sites responsible for positive chemotaxis, inhibited 
chemotaxis, and enzyme release are topographically closely linked or 
identical. 
Chemokinesis experiments demonstrated a requirement for Bacteroides 
cellular components or products to establish a concentration gradient 
across the Millipore membrane filter before neutrophil chemotaxis could 
take place. This indicates that the Bacteroides cellular components and 
products tested were truly chemotactic for neutrophils, and were not 
simply inducing random walk (chemokinesis) of the neutrophils. These 
findings agree with those of Casciato~~ (17), Zigmond and Hirsch (100) 
and others who have demonstrated that a concentration gradient is re-
quired for neutrophil chemotaxis. Furthermore, according to these 
investigators, it is essential (in describing any substance as being 
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"chemotactic" on the basis of its ability to induce migration in Boyden 
chamber) to provide evidence that the substance is capable of inducing 
directed movement (70). 
In this study, Bacteroides cellular components and products did 
not induce the release of lactate dehydrogenase (LOH). Lactate dehydro-
genase is strictly a cytoplasmic, non-lysosomal, enzyme; therefore, it 
is a marker of cell viability (34-36, 99). The lack of release of the 
non-granular enzyme, lactate dehydrogenase, indicates that cell damage 
was not necessary for extracellular release of the granular enzyme N-
acetyl- S-glucosaminidase. Also, in the absence of neutrophils, 
Bacteroides cellular components and products had no N-acetyl- S-glucosa-
minidase activity. 
When guinea pig serum complement was heat-inactivated (ss0c for 30 
minutes) and subsequently added to equal volumes of Bacteroides outer 
membrane or culture filtrates, neutrophil chemotaxis was still reduced 
and considerable enzyme release still occurred. This indicates the pro-
inhibitor, or whatever factor it may be, that is produced when Bacteroides 
cellular components or products are incubated with serum complement may 
be heat stable. 
Our results also indicated that when Bacteroides outer membrane or 
culture filtrates were incubated with purified CS fragment, PMN neutro-
phil chemotaxis was decreased, relative to the response to the CS frag-
ment alone. However, the same Bacteroides cellular components or pro-
ducts pre-incubated (at 37°c for 30 minutes) with guinea pig complement 
inhibited PMN neutrophil chemotaxis far more than when they were incu-
bated with just the purified CS fragment. This suggests that additional 
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serum factors in guinea pig complement, which were absent from purified 
C5 fragment, may be necessary for initiating inhibition of neutrophil 
chemotaxis by Bacteroides culture filtrates and outer membrane. 
Martin and Chaudhuri reported the only previous findings, that 
leukocyte migration was inhibited by gram negative bacterial components 
or products and they indicated that staphylococci and pneumococci were 
without effect (15). Bryant et tl presumed that the inhibition of neu-
trophil migration produced by gram negative cellular components or pro-
ducts reported by Martin and Chaudhuri was because gram negative bacterial 
products contain smaller and more dispersable particles than gram positive 
bacterial products. These gram negative products, as presumed by Bryant 
et tl, could be digested even in systems not designed to enhance cell-
particle contact and thus lead to inhibition of neutrophil chemotaxis 
(15). This assumption appeared to be based on the technique used by 
Martin and Chaudhuri (15). However, the present study examined the inter-
action of Bacteroides cellular components and products with Boyden's 
technique (14). Our data clearly contradict assumptions made by Bryant 
et~ and support the findings by Martin and Chaudhuri. Chemotaxis 
experiments with Boyden's technique are, according to ~Jard et tl (85-91), 
Zigmond and Hirsch (100), Kreutzer and Fantone (22), and Becker et tl 
(6-9), not only qualitative but also quantitative . This technique has 
proved to be the most widely used and accepted because of its reproduci-
bility (6). However, it should be noted that many of these investigators 
presently employ computers for determination of chemotactic counts, due 
to the very tedious nature of counting chemotaxis slides. In this study 
manual counting was employed, hence it was usually necessary to have a 
blind reading . 
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A relationship was shown between the amount of outer membrane of 
B. fragilis and the chemotactic response of rabbit peritoneal neutrophils 
(Figure 1). Ward, Lepow, and Newman previously demonstrated a direct 
relationship between the amount of 48 hour culture filtrate from Type 3 
pneumococcus and neutrophil chemotaxis (91). The slope of their line 
was greatest at lower doses (50µ1 and 100µ1). The data in Figure l, 
indicates that the sharpest rise in neutrophil chemotactic response to 
Bacteroides outer membrane was around 50 - 62µg/ml. This was the reason 
why 62.5µg/ml of either outer membrane or LPS were used routinely for 
the chemotaxis and enzyme release experiments. 
The incidence of anaerobic infections caused by gram negative 
bacteria has increased in recent years and§._. fragilis is the organism 
most frequently encountered in these human infections (29, 39-44, 53). 
Bacteroides may act synergistically with other obligate anaerobes [eg. 
Fusobacterium necrophorum (29, 312) in mixed infections to inhibit 
phagocytosis and killing of other bacteria; which, when present alone 
may not be virulent (29, 31, 38). Ingham et~ found that the inhibitory 
activity of these obligately anaerobic Bacteroides is due solely to an 
interaction with serum (38). Our data agree with his findings and also 
support his suggestion that there is need for study of the serum moiety 
or moieties affected by Bacteroides. The factor or effect produced by 
incubating Bacteroides cellular components or products (outer membrane 
and culture filtrates) with serum complement, behaves similarly to the 
neutrophil-i mmobilizing factor described by Goetz and Austen (27). The 
neutrophil-immobilizing factor is a low molecular weight, heat-stable 
substance liberated from neutrophils during maximum phagocytosis. This 
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immobilizing factor which inhibits neutrophil movement gives high yields 
of lysosomal enzymes (27). 
The high frequency of~· fraailis in clinical infections (31) has 
been postulated to be due to the resistance of most strains of~· fragilis 
to antibiotics (29, 31, 53). Tissue damage occurs when neutrophils 
release tissue destructive lysosomal enzymes into their surrounding 
environment (34, 99). These data indicate that in the presence of guinea 
pig serum complement, enzyme release is increased and neutrophil locomo-
tion is inhibited; interfering with phagocytosis. These findings coupled 
with the resistance of Bacteroides to antibiotics may well account for 
the fact that a combination of antibiotic therapy and surgical drainage 
of Bacteroides abscesses (71) is usually required for eradication of 
these infections. Furthermore, it is suggested that mixed flora infec-
tions due in part to Bacteroides may be attributed to the production of 
PMN neutrophil inhibitor(s); since the Bacteroides products from dif-
ferent strains were capable of producing similar neutrophilic responses. 
Little is known about cellular or whole body interaction with fac-
tors produced by bacteria (91, 96). Two neutrophil-associated serine 
esterases, one present as an active esterase the other as a proesterase, 
are required for the interaction of complement-derived factor with neu-
trophil - to cause chemotaxis (91). However, it is still not clear 
whether these same esterases are required for the neutrophils to re-
spond to bacterial chemotactic factors. 
Bacteroides fragilis produces many extracellular substances and the 
full array of extracellular enzymes produced by the genus Bacteroides 
is not known (68). Rudek and Haque have shown that Bacteroides produce 
50 
fibrinolysin, penicillinase, lysozyme, lecithinase, deoxyribonuclease, 
phosphatase, protease, gelatinase, lipase, elastase, chondroitin 
sulphatase and hyaluronidase (68). The roles of these enzymes in 
Bacteroides infectious processes is uncertain. In other bacteria (eg. 
staphylococci), elastase, hyaluronidase and chondroitin sulfatase have 
been suggested as invasive or spreading factors in the infectious pro-
cess (68). 
Further study concerning the response generated when serum comple-
ment and Bacteroides outer membrane or culture filtrates interact is 
needed. One should also examine the role played by extracellular enzymes 
produced by Bacteroides. The host defense mechanism(s) and the patho-
genicity of the infecting bacteria are important in bacterial infections; 
hence, further study of the interaction of Bacteroides purified products 
or cellular components may give a better understanding to the role 
Bacteroides plays in human infections. 
APPENDIX A 
Salts Solution (37a) 
Add the following as described: 
CaC1 2 (anhydrous) 
MgS04 (anhydrous) 
K2HP04 
KH 2Po4 
NaHC03 
NaCl 
0.2g 
0.2g 
l.Og 
l.Og 
10.0g 
2.0g 
Mix CaC1 2 and MgS04 in 300 ml distilled water until dissolved. Add 
500 ml distilled water and while stirring, slowly add the remaining 
salts. Continue swirling until all these salts are dissolved. Add 
200 ml distilled water, mix, and store at 4°c. 
51 
52 
APPENDIX B 
Pre-Reduced Chopped Meat Broth (37a) 
The following are added: 
Ground beef (fat free) 
di sti 11 ed water 
1 Normal NaOH 
500g 
lOOOml 
25ml 
Remove fat and connective tissue from lean beef before grinding. Mix 
meat, water and NaOH and bring this to a boil while stirring. Cool 
media to room temperature and then skim the fat off the surface. Filter 
the mixture retaining both meat oarticles and the filtrate. To the 
filtrate add sufficient water to restore it to the one liter original 
volume. 
To this filtrate add: 
Trypticase 
Yeast Extract 
Potassium Phosphate 
resazurin solution 
30g 
5g 
5g 
4ml (dissolve 
25mg of resazurin powder in 
lOOml distilled water). 
Boil the filtrate and cool under o2-free co2, then add 0.5g cysteine-HCl 
and 10.0ml hemin solution (dissolve 50mg of hemin in lml of lN NaOH, add 
99ml of distilled water and autoclave at 121oc for 15 minutes). Adjust 
PH of medium to neutrality. Under oxygen-free co2, dispense 7ml of broth 
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into tubes containing meat particles (use one part meat particles to 
four to five parts fluid). Stopper tubes and autoclave in press at 
121°c for 15 minutes. 
APPENDIX C 
Hank's Balanced Salts Solution (HBSS) (Flow Modified) 
Hank's lX Concentrated (22). 
Hank's lOX concentrateda 
Demineralized distilled water 
lM Tris (pH 7.3) 
1. lM Ca lei um Chloride (anhydrous) 
0.4M MgS04 
Glucose 
1.4% (wt/vol) NaHC03 
Adjusted to pH 7.2 - 7.4 
aHank's lOX Concentrated Buffer 
NaCl 
KCl 
Na2HP04 
KH 2Po4 
Demineralized distilled water 
50.0ml 
500.0ml 
13. 75ml 
0.825ml 
1.0ml 
1. lg 
50.0ml 
40.0g 
2.0g 
0.5g 
0.5g 
500.0ml 
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